Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells

Abstract

High-risk human papillomavirus (HPV) is a major causative agent of cervical cancer and the E6 and E7 genes encode the major HPV oncoproteins. The E7 protein from high-risk HPV types alters cell cycle progression and represses genes encoding components of the antigen-presentation pathway, suggesting a role for E7 in tumour immune evasion. We show that knockdown of E7 expression in HPV16- and HPV18-transformed cervical carcinoma cells by RNA interference increased expression of major histocompatibility complex (MHC) class I at the cell surface and reduced susceptibility of these cells to natural killer (NK) cells. Tetracycline-regulated induction of HPV16 E7 resulted in reduced expression of cell surface MHC class I molecules and increased NK cell killing. Our results suggest that, for HPV-associated malignancies, reduced MHC class I expression is the result of an active immune evasion strategy that has evolved to assist viral replication.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Abele R, Tampe R . (2006). Modulation of the antigen transport machinery TAP by friends and enemies. FEBS Lett 580: 1156–1163.

    Article  CAS  Google Scholar 

  • Berger AJ, Baege A, Guillemette T, Deeds J, Meyer R, Disbrow G et al. (2002). Insulin-like growth factor-binding protein 3 expression increases during immortalization of cervical keratinocytes by human papillomavirus type 16 E6 and E7 proteins. Am J Pathol 161: 603–610.

    Article  CAS  Google Scholar 

  • Bottley G, Cook GP, Blair GE . (2007). A flow cytometric assay for analysis of natural-killer cell-mediated cytolysis of adenovirus-transformed cells. Methods Mol Med 131: 221–230.

    Article  CAS  Google Scholar 

  • Bottley G, Cook GP, Meade JL, Holt JR, Hoeben RC, Blair GE . (2005). Differential expression of LFA-3, Fas and MHC Class I on Ad5- and Ad12-transformed human cells and their susceptibility to lymphokine-activated killer (LAK) cells. Virology 338: 297–308.

    Article  CAS  Google Scholar 

  • Brady CS, Bartholomew JS, Burt DJ, Duggan-Keen MF, Glenville S, Telford N et al. (2000). Multiple mechanisms underlie HLA dysregulation in cervical cancer. Tissue Antigens 55: 401–411.

    Article  CAS  Google Scholar 

  • Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS et al. (1998). HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391: 795–799.

    Article  CAS  Google Scholar 

  • Cromme FV, Airey J, Heemels MT, Ploegh HL, Keating PJ, Stern PL et al. (1994). Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J Exp Med 179: 335–340.

    Article  CAS  Google Scholar 

  • Cromme FV, Snijders PJ, van den Brule AJ, Kenemans P, Meijer CJ, Walboomers JM . (1993). MHC class I expression in HPV 16 positive cervical carcinomas is post-transcriptionally controlled and independent from c-myc overexpression. Oncogene 8: 2969–2975.

    CAS  Google Scholar 

  • Garcia-Lora A, Algarra I, Collado A, Garrido F . (2003). Tumour immunology, vaccination and escape strategies. Eur J Immunogenet 30: 177–183.

    Article  CAS  Google Scholar 

  • Georgopoulos NT, Proffitt JL, Blair GE . (2000). Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins. Oncogene 19: 4930–4935.

    Article  CAS  Google Scholar 

  • Hall AH, Alexander KA . (2003). RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells. J Virol 77: 6066–6069.

    Article  CAS  Google Scholar 

  • Hewitt EW . (2003). The MHC class I antigen presentation pathway: strategies for viral immune evasion. Immunology 110: 163–169.

    Article  CAS  Google Scholar 

  • Howley PM, Lowy DR . (2007). Papillomaviruses. In: Knipe DM (ed). Fields Virology, 5th edn. Lippincott Williams & Wilkins: USA, pp 2299–2354.

    Google Scholar 

  • Jackman M, Lindon C, Nigg EA, Pines J . (2003). Active cyclin B1-Cdk1 first appears on centrosomes in prophase. Nat Cell Biol 5: 143–148.

    Article  CAS  Google Scholar 

  • Jiang M, Milner J . (2002). Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 21: 6041–6048.

    Article  CAS  Google Scholar 

  • Kaznelson DW, Bruun S, Monrad A, Gjerlov S, Birk J, Ropke C et al. (2004). Simultaneous human papilloma virus type 16 E7 and cdk inhibitor p21 expression induces apoptosis and cathepsin B activation. Virology 320: 301–312.

    Article  CAS  Google Scholar 

  • Lanier LL . (2005). NK cell recognition. Annu Rev Immunol 23: 225–274.

    Article  CAS  Google Scholar 

  • Lee N, Llano M, Carretero M, Ishitani A, Navarro F, López-Botet M et al. (1998). HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 95: 5199–5204.

    Article  CAS  Google Scholar 

  • Li H, Ou X, Xiong J, Wang T . (2006). HPV16E7 mediates HADC chromatin repression and downregulation of MHC class I genes in HPV16 tumorigenic cells through interaction with an MHC class I promoter. Biochem Biophys Res Comm 349: 1315–1321.

    Article  CAS  Google Scholar 

  • Marin R, Ruiz-Cabello F, Pedrinaci S, Méndez R, Jiménez P, Geraghty DE et al. (2003). Analysis of HLA-E expression in human tumors. Immunogenetics 54: 767–775.

    CAS  Google Scholar 

  • Moretta L, Moretta A . (2004). Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J 23: 255–259.

    Article  CAS  Google Scholar 

  • O'Brien PM, Campo MS . (2003). Papillomaviruses: a correlation between immune evasion and oncogenicity? Trends Microbiol 11: 300–305.

    Article  CAS  Google Scholar 

  • Pett MR, Herdman MT, Palmer RD, Yeo GS, Shivji MK, Stanley MA et al. (2006). Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. Proc Natl Acad Sci USA 103: 3822–3827.

    Article  CAS  Google Scholar 

  • Proffitt JL, Sharma E, Blair GE . (1994). Adenovirus 12-mediated down-regulation of the major histocompatibility complex (MHC) class I promoter: identification of a negative regulatory element responsive to Ad12 E1A. Nucleic Acids Res 22: 4779–4788.

    Article  CAS  Google Scholar 

  • Tang S, Tao M, McCoy Jr JP, Zheng ZM . (2006). The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation. J Virol 80: 4249–4263.

    Article  CAS  Google Scholar 

  • Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12–19.

    Article  CAS  Google Scholar 

  • Zhao B, Ricciardi RP . (2006). E1A is the component of the MHC class I enhancer complex that mediates HDAC chromatin repression in adenovirus-12 tumorigenic cells. Virology 352: 338–344.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr M Jiang and Professor AJ Milner for advice on siRNA transfection, Dr J Pines for WT8 cells and A Trejdosiewicz and J Jarvis for technical assistance. This research was supported by Yorkshire Cancer Research, the Medical Research Council (UK) and the Danish Research Council for Nature and the Universe.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G E Blair.

Additional information

Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bottley, G., Watherston, O., Hiew, YL. et al. High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells. Oncogene 27, 1794–1799 (2008). https://doi.org/10.1038/sj.onc.1210798

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1210798

Keywords

This article is cited by

Search

Quick links